| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.31 | 1e-09 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.29 | 2e-08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |